European Journal of Dermatology
MENUDyshidrosiform pemphigoid due to nivolumab therapy Volume 31, issue 3, May-June 2021
Figures
1 Department of Dermatology and Plastic Surgery,
2 Department of Gastroenterological Surgery, Akita University Graduate School of Medicine, Akita, 010-8543, Japan
- DOI : 10.1684/ejd.2021.4052
- Page(s) : 411-2
- Published in: 2021
Dyshidrosiform pemphigoid (DP) is regarded as a unique type of bullous pemphigoid (BP) with vesiculobullous eruptions localized to the palms and soles, which clinically resembles dyshidrosiform eczema. Some cases of BP due to programmed cell death protein-1 (PD-1) inhibitor have been reported. Here, we report a case of DP after the administration of the PD-1 inhibitor, nivolumab, with histopathological features that differ from those of idiopathic DP.A 69-year-old man had received chemotherapy for [...]